This inventor holds 1 USPTO granted patent. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Maelle Vallade: Innovator in KDM5 Inhibitory Compounds
Introduction
Maelle Vallade is a prominent inventor based in Saffron Walden, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit KDM5 inhibitory activity. Her work is crucial in the fight against serious diseases such as cancer, Huntington's disease, and Alzheimer's disease.
Latest Patents
Maelle Vallade holds a patent for a compound having KDM5 inhibitory activity and its pharmaceutical use. This compound is represented by a general formula and is useful as a prophylactic and/or therapeutic agent for various diseases. The patent highlights the potential of this compound to serve as a vital tool in medical treatments.
Career Highlights
Throughout her career, Maelle Vallade has been associated with Ono Pharmaceutical Co., Ltd., where she has been able to apply her innovative ideas in a practical setting. Her dedication to research and development has led to advancements in therapeutic agents that can significantly impact patient care.
Collaborations
Maelle has collaborated with notable colleagues, including Akito Kakuuchi and Shuhei Umemura. These partnerships have fostered an environment of innovation and have contributed to the successful development of her patented compounds.
Conclusion
Maelle Vallade's work in developing KDM5 inhibitors showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic options in the treatment of critical diseases.